2896. Oral PrEP Uptake among HVTN 704/HPTN 085 Participants: Implications for the Future of Biomedical HIV Prevention Trials

BACKGROUND: The HVTN 704/HPTN 085 clinical trial (AMP study) assessed the efficacy of VRC01 broadly neutralizing antibody infusions for HIV prevention. It offered access to oral pre-exposure prophylaxis (PrEP) at no-cost to all participants as standard of HIV prevention care. Understanding PrEP init...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantos, Valeria D, Neradilek, Moni, Gillespie, Kevin, Huang, Yunda, deCamp, Allan C, Karuna, Shelly T, Edupuganti, Srilatha, del Rio, Carlos, Veloso, Valdilea, Cohen, Myron S, Donnell, Deborah J, Corey, Lawrence, Roxby, Alison C, Kelley, Colleen F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677201/
http://dx.doi.org/10.1093/ofid/ofad500.167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677201/
http://dx.doi.org/10.1093/ofid/ofad500.167

Ejemplares similares